Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

brivanib

Known as: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol 
A pyrrolotriazine-based compound and an inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) with potential antineoplastic activity… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
UNLABELLED Transarterial chemoembolization (TACE) is the current standard of treatment for unresectable intermediate-stage… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2014
Review
2014
Hepatocellular carcinoma (HCC) is a major health problem. Most patients with HCC experience a recurrence after resection/ablation… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Brivanib is a dual inhibitor of vascular-endothelial growth factor and fibroblast growth factor receptors that are… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Brivanib is a selective dual inhibitor of vascular endothelial growth factor and fibroblast growth factor receptors… Expand
Is this relevant?
Review
2013
Review
2013
The management of hepatocellular carcinoma (HCC) has substantially changed in the past few decades. Improvements in patient… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Review
2013
Review
2013
Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. HCC is an example of… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
200. [8] Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Purpose: Brivanib, a selective dual inhibitor of fibroblast growth factor and VEGF signaling, has recently been shown to have… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Purpose: Preclinical trials of a mouse model of pancreatic neuroendocrine tumors (PNET) were conducted to determine whether dual… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2011
Review
2011
Unlike most solid tumors, the incidence and mortality of hepatocellular carcinoma (HCC) have increased in the United States and… Expand
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?